Cargando…
Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus
Retroviral infection involves the reverse transcription of the viral RNA genome into DNA, which is subsequently integrated into the host cell genome. HIV-1 and other lentiviruses are able to mediate the infection of non-dividing cells through the ability of the capsid (CA) protein (1) to engage the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286700/ https://www.ncbi.nlm.nih.gov/pubmed/32483230 http://dx.doi.org/10.1038/s41564-020-0735-8 |
_version_ | 1784748075909120000 |
---|---|
author | Dharan, Adarsh Bachmann, Niklas Talley, Sarah Zwikelmaier, Virginia Campbell, Edward M. |
author_facet | Dharan, Adarsh Bachmann, Niklas Talley, Sarah Zwikelmaier, Virginia Campbell, Edward M. |
author_sort | Dharan, Adarsh |
collection | PubMed |
description | Retroviral infection involves the reverse transcription of the viral RNA genome into DNA, which is subsequently integrated into the host cell genome. HIV-1 and other lentiviruses are able to mediate the infection of non-dividing cells through the ability of the capsid (CA) protein (1) to engage the cellular nuclear import pathways of the target cell and mediate their nuclear translocation through components of the nuclear pore complex (NPC) (2–4). Although recent studies have observed the presence of capsid in the nucleus during infection(5–8), reverse transcription and disassembly of the viral core have conventionally been considered to be cytoplasmic events. Here, we use an inducible nuclear pore blockade to monitor the kinetics of HIV-1 nuclear import and define the biochemical staging of these steps of infection. Surprisingly, we observe that nuclear import occurs with relatively rapid kinetics (<5 hours) and precedes the completion of reverse transcription in target cells, demonstrating that reverse transcription completes in the nucleus. We also observe that HIV-1 remains susceptible to a capsid destabilizing compound PF74 following nuclear import, revealing that uncoating completes in the nucleus. We also observe that certain CA mutants are insensitive to a Nup62 mediated nuclear pore blockade in cells which potently block infection by wild type CA, demonstrating that HIV-1 can utilize distinct nuclear import pathways during infection. These studies collectively define the spatiotemporal staging of critical steps of HIV-1 infection and provide an experimental system to separate and thereby define the cytoplasmic and nuclear stages of infection by other viruses. |
format | Online Article Text |
id | pubmed-9286700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-92867002022-07-15 Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus Dharan, Adarsh Bachmann, Niklas Talley, Sarah Zwikelmaier, Virginia Campbell, Edward M. Nat Microbiol Article Retroviral infection involves the reverse transcription of the viral RNA genome into DNA, which is subsequently integrated into the host cell genome. HIV-1 and other lentiviruses are able to mediate the infection of non-dividing cells through the ability of the capsid (CA) protein (1) to engage the cellular nuclear import pathways of the target cell and mediate their nuclear translocation through components of the nuclear pore complex (NPC) (2–4). Although recent studies have observed the presence of capsid in the nucleus during infection(5–8), reverse transcription and disassembly of the viral core have conventionally been considered to be cytoplasmic events. Here, we use an inducible nuclear pore blockade to monitor the kinetics of HIV-1 nuclear import and define the biochemical staging of these steps of infection. Surprisingly, we observe that nuclear import occurs with relatively rapid kinetics (<5 hours) and precedes the completion of reverse transcription in target cells, demonstrating that reverse transcription completes in the nucleus. We also observe that HIV-1 remains susceptible to a capsid destabilizing compound PF74 following nuclear import, revealing that uncoating completes in the nucleus. We also observe that certain CA mutants are insensitive to a Nup62 mediated nuclear pore blockade in cells which potently block infection by wild type CA, demonstrating that HIV-1 can utilize distinct nuclear import pathways during infection. These studies collectively define the spatiotemporal staging of critical steps of HIV-1 infection and provide an experimental system to separate and thereby define the cytoplasmic and nuclear stages of infection by other viruses. 2020-09 2020-06-01 /pmc/articles/PMC9286700/ /pubmed/32483230 http://dx.doi.org/10.1038/s41564-020-0735-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Dharan, Adarsh Bachmann, Niklas Talley, Sarah Zwikelmaier, Virginia Campbell, Edward M. Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus |
title | Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus |
title_full | Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus |
title_fullStr | Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus |
title_full_unstemmed | Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus |
title_short | Nuclear pore blockade reveals HIV-1 completes reverse transcription and uncoating in the nucleus |
title_sort | nuclear pore blockade reveals hiv-1 completes reverse transcription and uncoating in the nucleus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286700/ https://www.ncbi.nlm.nih.gov/pubmed/32483230 http://dx.doi.org/10.1038/s41564-020-0735-8 |
work_keys_str_mv | AT dharanadarsh nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus AT bachmannniklas nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus AT talleysarah nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus AT zwikelmaiervirginia nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus AT campbelledwardm nuclearporeblockaderevealshiv1completesreversetranscriptionanduncoatinginthenucleus |